Clinical Orthopaedics and Related Research®

, Volume 468, Issue 11, pp 3019–3027 | Cite as

Factors Predicting Local Recurrence, Metastasis, and Survival in Pediatric Soft Tissue Sarcoma in Extremities

  • Chigusa Sawamura
  • Dempsey S. Springfield
  • Karen J. Marcus
  • Antonio R. Perez-Atayde
  • Mark C. Gebhardt
Symposium: Highlights of the ISOLS/MSTS 2009 Meeting

Abstract

Background

Pediatric soft tissue sarcomas are rare and differ from those in adults regarding the spectrum of diagnoses and treatment. Sarcomas in extremities may have different prognoses from those located elsewhere.

Questions/purposes

We sought risk factors predicting local recurrence, metastasis, and overall survival and asked whether radiation and chemotherapy influenced local recurrence, metastasis, and overall survival.

Methods

We retrospectively reviewed all 98 patients aged 18 years or younger diagnosed with soft tissue sarcomas in extremities from 1990 to 2008. Age, tumor size, depth, location, bone or neurovascular involvement, histologic subtypes, unplanned excision, surgical margins, metastasis at diagnosis, and adjuvant treatments were reviewed for each patient. We determined the effect of each prognostic variable on local recurrence, metastasis, and overall survival.

Results

Ninety-four patients underwent surgical excision and seven patients had local recurrence at a median time of 18.6 months. Radiation therapy reduced the rate of local recurrence. Fourteen patients had metastasis at diagnosis and seven patients later developed metastasis. The median time to metastasis was 20.9 months. Six patients died and the median time to death was 28.0 months. Metastasis at diagnosis was a predictive factor for death.

Conclusions

When limited to extremities, radiation therapy reduced the rate of local recurrence in pediatric soft tissue sarcomas. Metastases at diagnosis predict death.

Level of Evidence

Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.

Notes

Acknowledgments

We thank Andrew E. Rosenberg, MD, for evaluation of pathologic specimens.

References

  1. 1.
    Bell RS, O’Sullivan B, Liu FF, Powell J, Langer F, Fornasier VL, Cummings B, Miceli PN, Hawkins N, Quirt I, et al. The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am. 1989;71:370–375.PubMedGoogle Scholar
  2. 2.
    Blakely ML, Spurbeck WW, Pappo AS, Pratt CB, Rodriguez-Galindo C, Santana VM, Merchant TE, Prichard M, Rao BN. The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg. 1999;34:672–675.CrossRefPubMedGoogle Scholar
  3. 3.
    Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091–3102.PubMedGoogle Scholar
  4. 4.
    Ferrari A, Dileo P, Casanova M, Bertulli R, Meazza C, Gandola L, Navarria P, Collini P, Gronchi A, Olmi P, Fossati-Bellani F, Casali PG. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer. 2003;98:571–580.CrossRefPubMedGoogle Scholar
  5. 5.
    Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694–701.CrossRefPubMedGoogle Scholar
  6. 6.
    Guadagnolo BA, Zagars GK, Ballo MT, Strom SS, Pollock RE, Benjamin RS. Mortality after cure of soft-tissue sarcoma treated with conservation surgery and radiotherapy. Cancer. 2008;113:411–418.CrossRefPubMedGoogle Scholar
  7. 7.
    Lewis JJ, Leung D, Espat J, Woodruff JM, Brennan MF. Effect of reresection in extremity soft tissue sarcoma. Ann Surg. 2000;231:655–663.CrossRefPubMedGoogle Scholar
  8. 8.
    Lewis JJ, Leung D, Heslin M, Woodruff JM, Brennan MF. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol. 1997;15:646–652.PubMedGoogle Scholar
  9. 9.
    Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer. 2008;113:2575–2596.CrossRefPubMedGoogle Scholar
  10. 10.
    Loeb DM, Thornton K, Shokek O. Pediatric soft tissue sarcomas. Surg Clin North Am. 2008;88:615–627, vii.CrossRefPubMedGoogle Scholar
  11. 11.
    Marcus KC, Grier HE, Shamberger RC, Gebhardt MC, Perez-Atayde A, Silver B, Tarbell NJ. Childhood soft tissue sarcoma: a 20-year experience. J Pediatr. 1997;131:603–607.CrossRefPubMedGoogle Scholar
  12. 12.
    Palmerini E, Staals EL, Alberghini M, Zanella L, Ferrari C, Benassi MS, Picci P, Mercuri M, Bacci G, Ferrari S. Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution. Cancer. 2009;115:2988–2998.CrossRefPubMedGoogle Scholar
  13. 13.
    Pappo AS, Shapiro DN, Crist WM. Rhabdomyosarcoma. Biology and treatment. Pediatr Clin North Am. 1997;44:953–972.CrossRefPubMedGoogle Scholar
  14. 14.
    Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–581.CrossRefPubMedGoogle Scholar
  15. 15.
    Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–1689.PubMedGoogle Scholar
  16. 16.
    Rougraff BT, Davis K, Lawrence J. Does length of symptoms before diagnosis of sarcoma affect patient survival? Clin Orthop Relat Res. 2007;462:181–189.CrossRefPubMedGoogle Scholar
  17. 17.
    Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995;221:185–195.CrossRefPubMedGoogle Scholar
  18. 18.
    Spunt SL, Hill DA, Motosue AM, Billups CA, Cain AM, Rao BN, Pratt CB, Merchant TE, Pappo AS. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Clin Oncol. 2002;20:3225–3235.CrossRefPubMedGoogle Scholar
  19. 19.
    Spunt SL, Poquette CA, Hurt YS, Cain AM, Rao BN, Merchant TE, Jenkins JJ, Santana VM, Pratt CB, Pappo AS. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children’s Research Hospital. J Clin Oncol. 1999;17:3697–3705.PubMedGoogle Scholar
  20. 20.
    Stotter AT, A’Hern RP, Fisher C, Mott AF, Fallowfield ME, Westbury G. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer. 1990;65:1119–1129.CrossRefPubMedGoogle Scholar
  21. 21.
    Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol. 2009;27:3391–3397.CrossRefPubMedGoogle Scholar
  22. 22.
    Sultan I, Rodriguez-Galindo C, Saab R, Yasir S, Casanova M, Ferrari A. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients. Cancer. 2009;115:3537–3547.CrossRefPubMedGoogle Scholar
  23. 23.
    Trovik CS, Bauer HC. Local recurrence after surgery for soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl. 1999;285:45–46.PubMedGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2010

Authors and Affiliations

  • Chigusa Sawamura
    • 1
  • Dempsey S. Springfield
    • 2
  • Karen J. Marcus
    • 3
  • Antonio R. Perez-Atayde
    • 4
  • Mark C. Gebhardt
    • 5
    • 6
  1. 1.Harvard School of Public HealthBostonUSA
  2. 2.Department of Orthopaedic SurgeryMassachusetts General HospitalBostonUSA
  3. 3.Department of Radiation OncologyChildren’s HospitalBostonUSA
  4. 4.Department of PathologyChildren’s HospitalBostonUSA
  5. 5.Department of Orthopaedic SurgeryChildren’s HospitalBostonUSA
  6. 6.Department of Orthopaedic SurgeryBeth Israel Deaconess Medical CenterBostonUSA

Personalised recommendations